Home/Filings/4/0000810084-08-000007
4//SEC Filing

BIOJECT MEDICAL TECHNOLOGIES INC 4

Accession 0000810084-08-000007

CIK 0000810084operating

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 9:59 PM ET

Size

6.1 KB

Accession

0000810084-08-000007

Insider Transaction Report

Form 4
Period: 2008-01-22
Makar Ralph
CEO/President
Transactions
  • Award

    Series F Convertible Preferred Stock

    2008-01-22$0.75/sh+67,600$50,700324,267 total
    Exercise: $0.75From: 2008-01-22BJCT Common Stock (67,600 underlying)
Footnotes (3)
  • [F1]Paid by the cancellation of the outstanding principal and accrued interest of the 8% Convertible Promissory Note issued November 19, 2007.
  • [F2]No expiration date.
  • [F3]Includes Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000, Restricted Stock Unit 100,000.

Issuer

BIOJECT MEDICAL TECHNOLOGIES INC

CIK 0000810084

Entity typeoperating
IncorporatedOR

Related Parties

1
  • filerCIK 0000810084

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 9:59 PM ET
Size
6.1 KB